Giovanni Pascarella

Dr. Giovanni Pascarella

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Cell
Verified
Journal Article
Closed access
GPGiovanni Pascarella
Giovanni Pascarella
CHChung Chau Hon
Chung Chau Hon
KHKosuke Hashimoto
Kosuke Hashimoto
ABAnnika Busch
Annika Busch
JLJoachim Luginbühl
Joachim Luginbühl
Piero CarninciPiero Carninci
Piero Carninci

14 January 2023 in STAR Protocols
Verified
Journal Article
Open access
GPGiovanni Pascarella
Giovanni Pascarella
LSLetizia Straniero
Letizia Straniero
MFMartin Frith
Martin Frith
Piero CarninciPiero Carninci
Piero Carninci
Recombination of repeat elements is an important source of genomic variation in human tissues. Here, we describe steps to prepare libraries enriched for repeat elements starting from the genomic DNA of any species. We also detail the computational post-processing of the TE-reX pipeline output to generate datasets of putative somatic and polymorphic recombination events.

26 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAlice Lambolez
Alice Lambolez
PSPelin Sahlén
Pelin Sahlén
WKWenjing Kang
Wenjing Kang
XSXufeng Shu
Xufeng Shu
JSJessica Severin
Jessica Severin
Piero CarninciPiero Carninci
Piero Carninci
More than twenty years ago, the FANTOM consortium uncovered that mammalian genomes are pervasively transcribed, revealing multitudes of RNAs with unknown functions. A subset of these transcripts has since then been linked to transcriptional control and to chromatin organization via their ability to interact with DNA, suggesting that chromatin-associated RNAs could be key players in genome regulation. Although recent technological advances now enable the mapping of genome-wide RNA-DNA contacts, a lack of analyses integrating these methods with other genomic features and across multiple cellular contexts hinders our comprehensive understanding of the principles underlying RNA-DNA interactions and of their biological importance. As part of the FANTOM6 project, we thus generated RNA-DNA interaction maps in 16 different human cell types, then combined these contacts with multiple layers of other genomic data to investigate how patterns of interaction between RNA and DNA relate to chromatin organization and function. We show that the RNA-DNA interactome is highly dynamic yet reproducibly organized in cell-type specific networks, constituted of a great diversity of interactions that vary in function of their distance, the nature of their sources and the chromatin state of their targets. In particular, we detected numerous regulatory elements that exhibit marked changes in activity when differentially bound by transcripts, implying that thousands of RNA-DNA interactions can play a mechanistic role in gene expression. This regulatory function correlates with RNA-protein interactions and significantly associates with cell type-relevant and disorder-related traits. In addition to providing essential resources for future research in RNA-mediated chromatin regulation, cellular biology and human diseases, our study thus establishes the RNA-DNA interactome as a new genome regulatory layer that defines and maintains cellular identity and behavior.

20 November 2025 in bioRxiv
Verified
Preprint
Open access
GPGiovanni Pascarella
Giovanni Pascarella
MMMariia Mikhova
Mariia Mikhova
GPGargi Parkhi
Gargi Parkhi
JGJared Godfrey
Jared Godfrey
JHJoshua Heyza
Joshua Heyza
KMKatheryn Meek
Katheryn Meek
SUMMARY: Alu elements are short repeats that occupy approximately 10% of the human genome. The enrichment of primate genomes with Alu sequences occurred at the prosimian/new-world monkey evolutionary juncture, which coincided with a substantial increase in the expression levels of the Ku70/80 heterodimer. Previous work suggests that the elevated levels of Ku70/80 are required to prevent the activation of innate immune signaling pathways triggered by RNA molecules derived from Alu elements. Here we demonstrate that Ku regulates mRNA splicing, by inhibiting the use of alternative splice sites contained in intronic antisense Alu elements. Dysregulation of splicing precedes cell death and impacts genes involved in essential RNA metabolism processes, including splicing and ribosome biogenesis, likely impacting cell viability. We propose a model in which Ku binding of antisense Alu elements in introns of mRNAs modulates the use of alternative splice sites to balance beneficial and detrimental contributions of Alu repeats within primate genomes.

26 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GPGiovanni Pascarella
Giovanni Pascarella
MFMartin Frith
Martin Frith
Piero CarninciPiero Carninci
Piero Carninci
Non-allelic copies of the two major families of repeat elements in the human genome, Alu and L1, recombine somatically at high frequency. Tissue-specific recombination profiles are dynamic in cell differentiation and are altered in neurodegeneration, suggesting that somatic recombination of repeat elements can contribute to functional heterogeneity of cells in health and disease. The study of these genomic variants, however, presents several technical challenges related to their extremely low copy number and their sequence content. Here, we address key issues regarding detecting and annotating structural variants derived from recombining repeat elements in NGS data. We show that PCR introduces significant changes of recombination profiles in sequencing libraries and that recombination profiles are affected by the choice of sequencing platform. We refine previous estimates of recombination in single cells by analyzing recombination profiles in PCR-free HG002 datasets sequenced by Oxford Nanopore Technologies and PacBio sequencers while describing several platform-specific differences. We additionally provide evidence that recombination events annotated in state-of-the-art single-cell HG002 whole-genome sequencing datasets are likely molecular artifacts generated by PCR. By exploring the limits of current technologies, this work establishes essential requirements for future developments to enhance the reliability of detecting somatic recombination of repeat elements in genomic datasets.

26 August 2026 in Cells
Verified
Journal Article
Open access
PDF file
FMFederico De Marchi
Federico De Marchi
GCGiulia Ciotti
Giulia Ciotti
AAAlessandro Atanasio
Alessandro Atanasio
GPGiovanni Pascarella
Giovanni Pascarella
ASAlessandra Sperotto
Alessandra Sperotto
MGMichele Gottardi
Michele Gottardi
Artificial intelligence (AI) and machine learning (ML) now reach into every stage of AML care. Deep learning models read therapy-relevant mutations directly from bone marrow smears; automated flow cytometry gating reproduces expert calls in under a minute; and the first AI pathology devices for hematology have cleared regulatory review and entered clinical use. Beyond diagnosis, ML captures the age-dependent weight of individual mutations that categorical ELN scoring misses, drug response prediction for venetoclax–azacitidine has been validated across multiple external cohorts, and large language models are being tested for tumor board support and trial matching. The next wave, from clonal architecture modeling and single-cell foundation models to digital twins and reinforcement learning for adaptive dosing, could move AML management from reactive toward predictive, evolution-aware care. This review departs from existing AI-in-hematology surveys in three ways: we (i) restrict the scope to AML and organize the field around clinical decision points rather than technology categories, (ii) grade every tool on a five-tier author-defined clinical readiness level (CRL-AML 1–5), which exposes hundreds of models clustered at CRL-AML 1–2 and none yet in prospective clinical evaluation, and (iii) close with a numbered three-year agenda naming the consortia, datasets, and pragmatic trials needed to carry the field from publication to practice.